Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-043727
Filing Date
2013-08-08
Accepted
2013-08-08 17:14:13
Documents
1
Period of Report
2013-08-05

Document Format Files

Seq Description Document Type Size
1 RULE 10B5-1 PLAN TRANSACTION rrd387472.html 4  
1 RULE 10B5-1 PLAN TRANSACTION rrd387472.xml 4 6750
  Complete submission text file 0001181431-13-043727.txt   8312
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Issuer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 210 CARNEGIE CENTER PRINCETON NJ 08540
Business Address
KUEBLER CHRISTOPHER A (Reporting) CIK: 0001229877 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24006 | Film No.: 131023133